Drug Repurposing Market Set to Reach 42.20 Billion by 2030 Driven by Advancements in Disease Treatment and Regulatory Support

Mordor Intelligence has published a new report on Drug Repurposing Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction: The drug repurposing market is valued at USD 36.4 billion in 2025 and is expected to reach to USD 42.2 billion by 2030, translating into a 2.9% CAGR during the forecast period. Drug repurposing, also known as drug repositioning, involves the exploration of existing drugs for new therapeutic indications beyond their original use. The growing emphasis on speeding up the drug development process, coupled with regulatory incentives, has led to the increased adoption of drug repurposing strategies. As healthcare systems worldwide face the pressures of rising healthcare costs, drug repurposing presents a promising solution for addressing global health challenges in a more cost-effective manner.

Report Overview: https://www.mordorintelligence.com/industry-reports/drug-repurposing-market?utm_source=abnewswire

Key Trends:

*
Increased Focus on Rare Diseases: Drug repurposing is emerging as a strategic approach for treating rare and orphan diseases that have limited treatment options. By repurposing existing drugs, companies can potentially shorten development timelines and reduce associated costs while providing effective solutions to patients suffering from these conditions.

*
Collaboration with Academic Institutions: Many pharmaceutical companies are partnering with academic research institutions to identify potential candidates for repurposing. These collaborations allow for the pooling of knowledge and resources, facilitating faster identification of promising drug candidates for new indications.

*
Regulatory Support and Incentives: Governments and regulatory bodies have recognized the potential of drug repurposing to address urgent public health needs. Regulatory incentives, such as fast-track approvals and orphan drug designations, are being increasingly offered to accelerate the repurposing of drugs, especially for conditions with unmet medical needs.

*
Technological Advancements in AI and Data Analytics: The integration of artificial intelligence (AI) and big data analytics into drug repurposing is helping companies identify new uses for existing drugs. AI-based models can rapidly analyze large datasets, helping researchers predict how well a drug may perform in treating other diseases.

Market Segmentation:

The drug repurposing market is segmented based on therapy area, drug type, and region.

By Therapeutic Area

*
Oncology

*
CNS Disorders

*
Cardiovascular Diseases

*
Infectious Diseases

*
Metabolic Disorders

By Drug Molecule Type

*
Small-molecule Drugs

*
Biologics & Peptides

By Development Stage

*
Pre-clinical

*
Phase I

*
Phase II

*
Phase III

*
Approved / Marketed

By Route of Administration

*
Oral

*
Injectable

*
Topical / Others

By End User

*
Pharmaceutical & Biotech Companies

*
Academic & Research Institutes

*
Contract Research Organizations (CROs)

By Geography

*
North America

*
South America

*
Europe

*
Asia pacific

*
Middle east&Africa

Key Players:

The drug repurposing market is driven by numerous players, ranging from large pharmaceutical companies to specialized biotechnology firms. Key players in the market include:

*
Recursion Pharmaceuticals

*
BenevolentAI

*
Novartis AG

*
Pfizer Inc.

*
Roche Holding AG

Conclusion:

The drug repurposing market is expected to grow significantly as healthcare systems seek more efficient ways to deliver treatment options while controlling costs. The ability to shorten development timelines and reduce the risks associated with new drug discoveries makes repurposing a highly attractive strategy for pharmaceutical companies. With continued investment, regulatory support, and technological advancements, drug repurposing is poised to become a pivotal aspect of the future of medicine, offering potential solutions for a wide range of diseases, from common ailments to rare conditions.

As the market expands, stakeholders from all sectors, including pharmaceutical companies, biotechnology firms, academic researchers, and regulators, will play an essential role in shaping the future of drug repurposing, ultimately improving global health outcomes.

Industry Related Reports:

Drug Discovery Market [https://www.mordorintelligence.com/industry-reports/drug-discovery-market?utm_source=abnewswire]: The Drug Discovery Market Report is Segmented by Drug Type (Small Molecule, Biologic, and More), Technology (High Throughput Screening, Pharmacogenomics, and More), Process Workflow (Target Identification, Target Validation, and More), Therapeutic Area (Oncology, and More), End User (Pharmaceutical Companies, and More), and Geography (North America, Europe, and More).

Pharmaceutical Equipment Market [https://www.mordorintelligence.com/industry-reports/pharmaceutical-equipment-market?utm_source=abnewswire]: The Pharmaceutical Equipment Market Report Segments the Industry Into by Type (Weighing Equipment, Lyophilizer, Pharmaceutical Water Equipment, Granulating Equipment, Packaging Equipment, Others), by Formulation (Tablets, Capsules, Injectables, Other Formulations), by End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing Companies, Others), and Geography (North America, Europe, Asia-Pacific, and More).

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=drug-repurposing-market-set-to-reach-4220-billion-by-2030-driven-by-advancements-in-disease-treatment-and-regulatory-support]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.